WGS Q2 volumes rise 32% on new markets and automation
WGS said Q2 volumes grew 32%, attributing momentum to core channels and expansion into primary care and prenatal markets underway. Management cited untapped potential in geneticists, pediatric neurology and NICU, plus collection-rate and gross-margin improvements.